330
Participants
Start Date
January 22, 2025
Primary Completion Date
August 27, 2025
Study Completion Date
August 27, 2025
Candin, Intradermal Solution
Injection at the base of the selected wart
Placebo
Injection at the base of the selected wart
Bryn Mawr Health Center, Newtown Square
Velocity Clinical Hampton, Hampton
Velocity Clinical Spartanburg, Spartanburg
Cahaba Dermatology, Birmingham
Hamzavi Dermatology, Fort Gratiot
Kaminska Dermatology, Chicago
Schlessinger MD, Omaha
Dermatology Clinic of Arkansas, Hot Springs
Arkansas Pediatric Clinic, Bryant
Johnson Dermatology, Fort Smith
Austin Institute for Clinical Research, Pflugerville
DermResearch, Austin
Velocity Clinical Englewood, Englewood
Long Beach Research, Long Beach
Velocity Clinical La Mesa, La Mesa
Integrative Skin Research, Sacramento
Integrated Dermatology of Newton-Brighton, Brighton
Advocare Berlin Medical Associates, Berlin
Lead Sponsor
Nielsen BioSciences, Inc.
INDUSTRY